🟩 Trump’s Asia tour has set the stage for a high-stakes trade showdown that could reshape the region’s tech, pharma, and rare earth sectors for years to come. With tariffs looming and supply chains on the line, what’s really at stake for Malaysian semiconductor giants and Singapore’s $15B pharmaceutical exports?
In this exclusive interview, Ivanna sits down with Iggy from The Investing Iguana to break down:
Trump’s meetings in Malaysia, Japan, and South Korea—and the critical Oct 30 summit with Xi Jinping
How US-China tensions threaten Malaysia’s chip exports, supply chain resilience, and regional growth
The hidden power of China’s rare earth restrictions and their impact on global tech and defense
Why Singapore’s role as a “safe haven” is in question, especially for blue-chip pharma stocks
Practical moves investors can make to navigate volatility and seize long-term opportunities
🔔 Make sure to SUBSCRIBE and turn on notifications, so you never miss any of our videos: https://www.youtube.com/@InvestingIguana?sub_confirmation=1
❤️ Join as a member for just $3 per month to buy me a coffee for my efforts. You also benefit from full access to scheduled videos.
🅰️ Follow my Substack for In-depth Analysis and Deep-Dives at https://investingiguana.substack.com
